[Correction of metabolic disturbances in cancer patients in the early postanesthesia period].
Fatullaeva
K F
KF
Nurov
A U
AU
Saltanov
A I
AI
D000328:Adult; D000368:Aged; D000768:Anesthesia, General / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000008:administration & dosage*; D005500:Follow-Up Studies; D013509:Gynecologic Surgical Procedures / Q000379:methods; D006801:Humans; D000860:Hypoxia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D007290:Inosine Diphosphate / Q000008:administration & dosage*; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*; D009536:Niacinamide / Q000008:administration & dosage*; D011184:Postoperative Period; D013386:Succinates / Q000008:administration & dosage*; D016896:Treatment Outcome
D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D008315:Malondialdehyde; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate